课题基金 / 基金详情

Understanding plasticity and the ecological relevance of behavioural responses in fish to neuroactive pharmaceutical

Understanding plasticity and the ecological relevance of behavioural responses in fish to neuroactive pharmaceutical
了解鱼类行为反应与神经活性药物的可塑性和生态相关性
批准号:
2480936
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Wildlife are exposed to a wide range of human pharmaceuticals at low (part per billion or trillion) concentrations, which in the case of neuroactive pharmaceuticals have been shown to induce changes in behavioural phenotypes in fish and invertebrates. These findings are generally based on short-term laboratory studies that focus on detecting a behavioural response and it is unclear if responses are transient, permanent or impactful on growth, reproduction or survival. This studentship will aim to characterise and link neurological responses to changes in behavioural phenotypes and phenotypic plasticity in zebrafish driven by key pharmaceuticals. Partial and full life-cycle exposure studies will be used to evaluate the molecular mechanisms, behavioural effects and fitness impacts of different pharmaceutical exposures, at different life stages, on different genetic strains.The student will join a large and vibrant research team at Exeter and will work as part of a wider European project focussed on understanding the effects of pharmaceuticals in the environment. The student will also have access to exceptional facilities and expertise at Exeter, and will receive training in animal behaviour, molecular biology, imaging, bioinformatics and toxicology. The student will also benefit from working with industry experts from AstraZeneca, thus greatly enhancing their long term career prospects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
中性粒细胞在体内条件下重编程为造血干祖细胞的研究
  • 批准号:
    92068101
  • 项目类别:
    重大研究计划
  • 资助金额:
    80.0万元
  • 批准年份:
    2020
  • 负责人:
    程林
  • 依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
  • 批准号:
    92068107
  • 项目类别:
    重大研究计划
  • 资助金额:
    79.0万元
  • 批准年份:
    2020
  • 负责人:
    王丽
  • 依托单位:
Hippo通路调控胃解痉多肽表达型化生及恶性转化的功能机制
  • 批准号:
    31930026
  • 项目类别:
    重点项目
  • 资助金额:
    308.0万元
  • 批准年份:
    2019
  • 负责人:
    周兆才
  • 依托单位: